Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
COPD (Chronic Obstructive Pulmonary Disease): full-pipeline trial registry
9 of 10 indexed COPD (Chronic Obstructive Pulmonary Disease) trials are currently recruiting.
Corpus placement: #1,724 of 28,707 conditions by registered trial count.
10 US clinical trials · 9 currently recruiting · #1,724 of 28,707 conditions by registered trial count
COPD (Chronic Obstructive Pulmonary Disease): 10 US clinical trials tracked, 9 recruiting.
COPD (Chronic Obstructive Pulmonary Disease) is the subject of 10 registered US clinical trials on ClinicalTrials.gov, 9 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is University of Tennessee Graduate School of Medicine, running 1 of these trials.
Enrollment posture brief
Registry condition copd-chronic-obstructive-pulmonary-disease
OPEN 9 | RECR 90% | LATE 2 | EARLY 2 | RANK #1724 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Circadian Rhythm (90% recruiting · 10 trials)
COPD (Chronic Obstructive Pulmonary Disease) lists 9 open slots (90% of 10 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for COPD (Chronic Obstructive Pulmonary Disease) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
COPD (Chronic Obstructive Pulmonary Disease) is recruiting above its size-band peers.
9 of 10 indexed trials (90%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of COPD (Chronic Obstructive Pulmonary Disease) trials is spread across many organizations.
University of Tennessee Graduate School of Medicine accounts for 1 of 10 trials (10%). 10 distinct sponsors appear on at least one study for this condition label.
-
Typical COPD (Chronic Obstructive Pulmonary Disease) enrolment sits around 200 participants.
Median target enrolment is 200 among the 10 trials that report a genuine target (sentinel values excluded). 4 of those (40%) plan for fewer than 100 participants.
-
COPD (Chronic Obstructive Pulmonary Disease) research is mostly interventional.
8 interventional and 2 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
10 total, page 1 of 1
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
AstraZeneca
NCT06283966
Validation of Chronic Obstructive Pulmonary Disease (COPD) Algorithm
Wake Forest University Health Sciences
NCT07223749
Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD
University of California, San Francisco
NCT05572632
University of Michigan COPD Identification Through Lung Cancer Screening Cohort Study - MAP2
University of Michigan
NCT07482475
OMEGA - Dietary Intervention - COPD Trial
Johns Hopkins University
NCT05297279
Compare the Effects of Nebulizer Versus Inhaler Based Therapy for COPD Using Long-acting Bronchodilators
University of Tennessee Graduate School of Medicine
NCT07133880
Evaluation of the Paramedic Evaluation for Acute COPD Exacerbation
University of Massachusetts, Worcester
NCT07072039
Photon-counting CT in Chest Imaging
Duke University
NCT07031336
Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia
Bastiaan Driehuys
NCT07037836
A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD
Generate Biomedicines
NCT07116889
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Phase 3 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on COPD (Chronic Obstructive Pulmonary Disease) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on COPD (Chronic Obstructive Pulmonary Disease) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this COPD (Chronic Obstructive Pulmonary Disease) page
10 registered trials, 9 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 9 COPD (Chronic Obstructive Pulmonary Disease) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Tennessee Graduate School of Medicine sponsors the most COPD (Chronic Obstructive Pulmonary Disease) trials on record, review their full trial history before evaluating a specific study. See University of Tennessee Graduate School of Medicine's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This COPD (Chronic Obstructive Pulmonary Disease) condition card totals 10 registered trials; most-linked intervention Placebo (SC); top US site state North Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.